Items Tagged with 'Primary Care'


article image

The Power of SGLT2 Inhibitors to Improve Renal Outcomes in CKD

CME: 1.0
With the expanding use of SGLT2 inhibitors beyond glucose control, this AI-driven activity will inform clinicians about the available evidence assessing their efficacy and safety in CKD, renoprotective benefits in patients with CKD with and without T2DM, evolving practice standards, and their relevance to patient care.
Read More